If I understand correctly, as I said before, we're just adjusting the instrument. Before changing or adjusting fees, whatever they may be—
we would consult all our stakeholders. There's a requirement to do that and it's in the legislation. The FDA says, thou shalt consult your stakeholders on this before updating any fee.
We currently have fees, as you know, and we've had them for about 22 years. They've only been updated once in those 22 years. The last consultation was in 2011, pursuant to a full consultation. It was also presented here as well.